We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AXON:NASDAQAxon Enterprise, Inc. Analysis

Data as of 2026-09-05 - not real-time

$515.67

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Axon Enterprise, Inc. is bullish at $515.67, with short-term averages leading the long-term ones. It has gained 2.7% over the past 30 days. With RSI at 40.7 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $499.00 up to resistance at $651.61.
The shares look overvalued, trading on 222.3 times earnings above a sector average of 28.5. The average analyst target implies 34.5% above today's level. Revenue is growing at 35.3% on a 6.2% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 85.1%, a beta of 1.61 and a maximum drawdown of 55.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

AXON heads into Q2 results with strong revenue growth expectations as demand across devices and software offsets rising...Axon Enterprise stock trades in the mid-$600s as investors react to Q2 2026 revenue growth of 35 perOne trades at a premium valuation with steady growth in public safety tech; the other is burning cash despite a 80% net...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 505.56
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 222.3 versus sector average of 28.5
  • Trading above the 200-day average of 505.56

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 222.3 versus sector average of 28.5
  • Analyst targets imply +34.5% versus the current price
  • Revenue growth of +35.3%

Key Metrics & Analysis

Financial Health

Revenue Growth35.30%
Profit Margin6.19%
P/E Ratio222.3
ROE6.22%
ROA0.51%
Debt/Equity50.36
P/B Ratio11.4
Op. Cash Flow$265.8M
Free Cash Flow$222.2M
Industry P/E28.5

Technical Analysis

TrendBullish
RSI40.7
Support$499.00
Resistance$651.61
MA 20$592.43
MA 50$566.83
MA 200$505.56
MACDBearish
VolumeStable
Fear & Greed Index95.48

Valuation

Fair Value$80.11
Target Price$693.40
Upside/Downside34.47%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.61
Volatility85.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.